logo
Search orAI Icon𝛼SK
ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

251
Analysis
Health Care • United States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
bullish•Ci:z Holdings
•23 Oct 2018 19:40

J&J Tenders for Ci:z Holdings

Today after the close, Johnson & Johnson (JNJ US)announced a US$2bn+ deal and Tender Offer to buy the 52% of Ci:z Holdings (4924 JP) not held...

Logo
Travis Lundy
678 Views
Share
bearish•Celltrion Inc
•22 Oct 2018 19:04

Celltrion Inc Placement - Shorter Lockup Period Will Be an Overhang for Share Price

Ion Investment (Temasek) is looking to sell about 3.4m shares in Celltrion Inc (068270 KS) in an accelerated bookbuild worth approximately US$740m....

Logo
Share
bearish•Celltrion Inc
•21 Sep 2018 20:00

Celltrion: Understanding Inflectra's U.S. Challenges

Celltrion Inc (068270 KS) 's Inflectra (biosimilar of Remicade marketed in the U.S.) has struggled to gain a foothold in the market since its...

Logo
Share
bearish•Celltrion Inc
•08 Aug 2018 03:59

Celltrion: Manufacturing Risks Remain

Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...

Logo
Share
bearish•Celltrion Inc
•26 Jul 2018 11:26

Sell Celltrion Inc (068270 KS): Story Unravelling

UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x